Picture Berlin Partner Hotspot for Startups 650x80px
Organisation › Details

Molomics Biotech S.L.

Molomics Biotech, SL is a drug discovery and development company based on a proprietary/patented technology that allows to design safer and more efficacious therapeutics. Molomics principal focus is Parkinson's Disease. Current programs address Levodopa Induced Dyskinesia, a movement disorder, and Neuroprotection. Molomics Technology integrates Artificial Intelligence with specialists and their Collective Intelligence to effectively search for structurally novel small molecule therapeutics. As molecules are designed collaboratively in silico between machine and humans, we expect that our drug candidates are more efficacious and safer, increasing the success rate in clinical development. *


Period Start 2019-10-22 existent
Products Industry AI-based drug discovery
  Industry 2 Parkinson drug
Person Person Blobel, Jascha (Molomics Biotech 201910 CEO)
Region Region Barcelona
  Country Spain (España)
  Street 4–8 Baldiri i Reixac
Parc Científic de Barcelona
  City 08028 Barcelona
  Tel +34-661-544028
    Address record changed: 2021-02-13
Basic data Employees n. a.
    �About Section� taken from web site of organisation on 29.10.
Record changed: 2020-08-04


Picture [iito] Plain Stupid Simple 650x80px

More documents for Molomics Biotech S.L.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Network in German Capital Region 650x80px

» top